These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 2525236

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Clinical assessment of 99mTc-MAG3 scintigraphy for impaired renal function].
    Sato M, Hirayama K, Ishikawa N, Takeda T, Wu J, Itai Y, Kobayashi M, Koyama A.
    Kaku Igaku; 1994 Jan; 31(1):75-84. PubMed ID: 8309113
    [Abstract] [Full Text] [Related]

  • 23. Comparison of technetium-99m MAG3 kit with HPLC-purified technetium-99m MAG3 and OIH in rats.
    Coveney JR, Robbins MS.
    J Nucl Med; 1987 Dec; 28(12):1881-7. PubMed ID: 2960790
    [Abstract] [Full Text] [Related]

  • 24. [A comparison of different methods of calculating clearances using 99mTc-mercaptoacetyltriglycine and 123I- or 131I-ortho-iodohippuric acid].
    Keske U, Cordes M, Hosten N, Roll D, Hunger J, Felix R.
    Nuklearmedizin; 1990 Jun; 29(3):93-100. PubMed ID: 2144045
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Evaluation of 99Tcm-bicisate as a renal imaging agent.
    Ozker K, Kabasakal L, Liu Y, Hellman RS, Isitman A, Krasnow AZ, Collier BD.
    Nucl Med Commun; 1997 Aug; 18(8):771-5. PubMed ID: 9293508
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Technetium-99m-MAG3 versus iodine-123-OIH: renal clearance and distribution volume as measured by a constant infusion technique.
    Prenen JA, de Klerk JM, van het Schip AD, van Rijk PP.
    J Nucl Med; 1991 Nov; 32(11):2057-60. PubMed ID: 1834812
    [Abstract] [Full Text] [Related]

  • 29. Phase II study of Tc-99m MAG3 in patients with nephrourologic diseases.
    Itoh K, Tsukamoto E, Kakizaki H, Nonomura K, Koyanagi T, Furudate M, Torizuka K.
    Clin Nucl Med; 1993 May; 18(5):387-93. PubMed ID: 8508572
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Filtration fraction and its implications for radionuclide renography using diethylenetriaminepentaacetic acid and mercaptoacetyltriglycine.
    Gates GF.
    Clin Nucl Med; 2004 Apr; 29(4):231-7. PubMed ID: 15096969
    [Abstract] [Full Text] [Related]

  • 32. [Advantages of the new radiopharmaceutic agent, 99mTC-mercaptoacetyltriglycine (99mTc-MAG3), in the diagnosis of kidneydiseases. A comparative study with 131I-OIH, 99mTc-DTPA and 99mTc-DMSA].
    Lepej J, Marosová A, Kliment J, Buchanec J, Svitác J, Klisenbauer L.
    Bratisl Lek Listy; 1992 May; 93(5):258-65. PubMed ID: 1327424
    [Abstract] [Full Text] [Related]

  • 33. Renogram comparison of p-[(18)F]fluorohippurate with o-[(125)I]iodohippurate and [(99m)Tc]MAG3 in normal rats.
    Pathuri G, Sahoo K, Awasthi V, Gali H.
    Nucl Med Commun; 2011 Oct; 32(10):908-12. PubMed ID: 21876402
    [Abstract] [Full Text] [Related]

  • 34. Will 99mTc-MAG3 replace 131I-OIH and 99mTc-DTPA in the follow-up of renal transplants?
    Dubovsky EV, Russell CD, Yester MV, Thorstad BL, Ryan JP.
    Contrib Nephrol; 1990 Oct; 79():118-22. PubMed ID: 2146081
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Functional parameters calculated by 99mTc-MAG3 in transplanted kidney].
    Koizumi K, Yamaguchi M, Tooyama K, Uchiyama G, Yamada Y, Ueno A.
    Kaku Igaku; 1994 Jan; 31(1):17-25. PubMed ID: 8309107
    [Abstract] [Full Text] [Related]

  • 37. Technetium-99m-N,N-ethylenedicysteine--a comparative study of renal scintigraphy with technetium-99m-MAG3 and iodine-131-OIH in patients with obstructive renal disease.
    Ozker K, Onsel C, Kabasakal L, Sayman HB, Uslu I, Bozluolçay S, Cansiz T, Kapicioğlu T, Urgancioğlu I.
    J Nucl Med; 1994 May; 35(5):840-5. PubMed ID: 8176468
    [Abstract] [Full Text] [Related]

  • 38. Effects of altered physiologic states on clearance and biodistribution of technetium-99m MAG3, iodine-131 OIH, and iodine-125 iothalamate.
    Taylor A, Eshima D.
    J Nucl Med; 1988 May; 29(5):669-75. PubMed ID: 2967354
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Diuresis renography. A simultaneous comparison between 131I-hippuran and 99Tcm-MAG3.
    Hvid-Jacobsen K, Thomsen HS, Nielsen SL.
    Acta Radiol; 1990 Jan; 31(1):83-6. PubMed ID: 2140270
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.